NEOGENOMICS INC (NEO) — insider trading
Health Care · NASDAQ
NEOGENOMICS INC (NEO) has 58 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 58 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion (derivative) | 17,562 | — | $0 | Form 4 |
| 2026-10-01 | Stone Warren | Officer (Pres & Chief Operating Officer) | Shares withheld for taxes / exercise cost | 6,911 | — | $0 | Form 4 |
| 2026-10-01 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion | 17,562 | — | $0 | Form 4 |
| 2026-09-01 | Olivo Alicia C | Officer (EVP, GC & Business Development) | Shares withheld for taxes / exercise cost | 2,692 | — | $0 | Form 4 |
| 2026-08-21 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion (derivative) | 28,106 | — | $0 | Form 4 |
| 2026-08-21 | Stone Warren | Officer (Pres & Chief Operating Officer) | Shares withheld for taxes / exercise cost | 11,060 | — | $0 | Form 4 |
| 2026-08-21 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion | 28,106 | — | $0 | Form 4 |
| 2026-08-04 | Aunan Greg D | Officer (Chief Accounting Officer) | Open-market sale | 20,000 | $16.07 | $321.4K | Form 4 |
| 2026-06-23 | Starrett Carolyn S | Director | Grant / award / vesting (derivative) | 14,125 | — | $0 | Form 4 |
| 2026-06-23 | Starrett Carolyn S | Director | Grant / award / vesting (derivative) | 9,784 | — | $0 | Form 4 |
| 2026-06-15 | TETRAULT LYNN A. | Director | Open-market sale | 5,307 | $11.10 | $58.9K | Form 4 |
| 2026-06-09 | TETRAULT LYNN A. | Director | Open-market sale | 5,307 | $11.29 | $59.9K | Form 4 |
| 2026-06-01 | Green Marjorie C | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Green Marjorie C | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Green Marjorie C | Director | Option exercise / conversion (derivative) | 22,964 | — | $0 | Form 4 |
| 2026-06-01 | Green Marjorie C | Director | Option exercise / conversion | 22,964 | — | $0 | Form 4 |
| 2026-06-01 | Gunn Neil | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Gunn Neil | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Gunn Neil | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Gunn Neil | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | KANOVSKY STEPHEN M | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | KANOVSKY STEPHEN M | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | KANOVSKY STEPHEN M | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | KANOVSKY STEPHEN M | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Kelly Michael Aaron | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Kelly Michael Aaron | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Kelly Michael Aaron | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Kelly Michael Aaron | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Perez David Brian | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Perez David Brian | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Perez David Brian | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Perez David Brian | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | TETRAULT LYNN A. | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | TETRAULT LYNN A. | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | TETRAULT LYNN A. | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | TETRAULT LYNN A. | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Williams Felicia | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Williams Felicia | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Williams Felicia | Director | Option exercise / conversion (derivative) | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Williams Felicia | Director | Option exercise / conversion | 23,077 | — | $0 | Form 4 |
| 2026-06-01 | Kenny John P. | Director | Grant / award / vesting (derivative) | 15,970 | — | $0 | Form 4 |
| 2026-06-01 | Kenny John P. | Director | Grant / award / vesting (derivative) | 11,069 | — | $0 | Form 4 |
| 2026-06-01 | Kenny John P. | Director | Option exercise / conversion (derivative) | 5,893 | — | $0 | Form 4 |
| 2026-06-01 | Kenny John P. | Director | Option exercise / conversion | 5,893 | — | $0 | Form 4 |
| 2026-05-11 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion (derivative) | 5,830 | — | $0 | Form 4 |
| 2026-05-11 | Stone Warren | Officer (Pres & Chief Operating Officer) | Shares withheld for taxes / exercise cost | 3,783 | — | $0 | Form 4 |
| 2026-05-11 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion | 5,830 | — | $0 | Form 4 |
| 2026-05-11 | Olivo Alicia C | Officer (EVP, GC & Business Development) | Option exercise / conversion (derivative) | 3,944 | — | $0 | Form 4 |
| 2026-05-11 | Olivo Alicia C | Officer (EVP, GC & Business Development) | Shares withheld for taxes / exercise cost | 2,559 | — | $0 | Form 4 |
| 2026-05-11 | Olivo Alicia C | Officer (EVP, GC & Business Development) | Option exercise / conversion | 3,944 | — | $0 | Form 4 |
| 2026-05-02 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion (derivative) | 5,969 | — | $0 | Form 4 |
| 2026-05-02 | Stone Warren | Officer (Pres & Chief Operating Officer) | Shares withheld for taxes / exercise cost | 2,349 | — | $0 | Form 4 |
| 2026-05-02 | Stone Warren | Officer (Pres & Chief Operating Officer) | Option exercise / conversion | 5,969 | — | $0 | Form 4 |
| 2026-05-02 | Aunan Greg D | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 5,372 | — | $0 | Form 4 |
| 2026-05-02 | Aunan Greg D | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 1,309 | — | $0 | Form 4 |
| 2026-05-02 | Aunan Greg D | Officer (Chief Accounting Officer) | Option exercise / conversion | 5,372 | — | $0 | Form 4 |
| 2026-05-01 | Olivo Alicia C | Officer (EVP, GC & Business Development) | Shares withheld for taxes / exercise cost | 1,042 | — | $0 | Form 4 |
| 2026-05-01 | Aunan Greg D | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 937 | — | $0 | Form 4 |
Ask the chat about NEO's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NEOGENOMICS INC (NEO).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.